中医药调控细胞自噬抗肝纤维化的研究进展
Research Progress of Chinese Medicine Regulating Autophagy against Liver Fibrosis
DOI: 10.12677/TCM.2024.131030, PDF,    国家科技经费支持
作者: 何广英, 王燕凤, 张 臻, 谢婷婷, 韦柳婷:广西中医药大学研究生院,广西 南宁;胡振斌:广西中医药大学第一附属医院,广西 南宁
关键词: 中药细胞自噬肝纤维化综述研究进展Herbalism Cellular Autophagy Liver Fibrosis Review Research Advances
摘要: 肝纤维化是机体对各种因素诱导的慢性病肝损伤进行的修复愈合反应,与肝硬化、肝癌的发生存在一定关系,阻止或逆转肝纤维化对于减少肝硬化和肝癌的发生至关重要。在中医学中,这一过程常被归类为“臌胀”和“积聚”等病证,往往涉及到“虚损生积”的病理机制。自噬是细胞生长、存活及自我平衡的重要过程。自噬的失调参与多种疾病的发生、发展。研究表明,细胞自噬与肝纤维化的发生、发展、转归过程有相关性,因此通过对细胞自噬进行调控可能为逆转肝纤维化提供了新的治疗策略。数十年的研究证明,中医药治疗肝纤维化疗效确切,其作用机制与细胞自噬及其相关因子或通路密切相关。该文通过总结和归纳近年来中医药通过干预细胞自噬过程,进而对肝纤维化发挥治疗作用进行综述,为中医药应用于肝纤维化进程方面提供思路和借鉴。
Abstract: Liver fibrosis is the body’s recovery and healing response to chronic liver damage caused by a vari-ety of factors, and it is also the early stage of cirrhosis. At the same time, it has a certain relationship with the occurrence of liver cancer. Preventing or reversing liver fibrosis is the key. In Chinese medicine, there are several classifications: such as “expansion” and “accumulation”, and the patho-genesis is mostly “virtual loss and accumulation”. Autophagy is an important process of cell growth, survival and homeostasis. The disorder of autophagy is involved in the occurrence and development of many diseases. Studies have shown that autophagy is related to the occurrence, development and outcome of liver fibrosis, so the regulation of autophagy may provide a new therapeutic strategy for reversing liver fibrosis. Decades of research have proved that Chinese medicine is effective in treat-ing liver fibrosis, and its mechanism of action is closely related to autophagy and its related factors or pathways. This article summarizes the therapeutic effects of traditional Chinese medicine on liv-er fibrosis through the intervention of autophagy in recent years, and provides ideas and references for the use of medicinal plants in hepatic fibrosis.
文章引用:何广英, 王燕凤, 张臻, 谢婷婷, 韦柳婷, 胡振斌. 中医药调控细胞自噬抗肝纤维化的研究进展[J]. 中医学, 2024, 13(1): 188-195. https://doi.org/10.12677/TCM.2024.131030

参考文献

[1] 徐列明, 刘平, 沈锡中, 等. 肝纤维化中西医结合诊疗指南(2019年版) [J]. 临床肝胆病杂志, 2019(7): 1444-1449.
[2] Roehlen, N., Emilie, C. and Baumert, T.F. (2020) Liver Fibrosis: Mechanical Concepts and Therapeutic Perspectives. Cells, 9, 875.
[3] 何苗, 向霞, 徐如青, 等. HBV相关肝纤维化小鼠模型的建立及关键表型深度分析研究[J]. 中国实验动物学报, 2023, 31(2): 187-193.
[4] Li, X.H., He, S.K. and Ma, B.Y. (2020) Autophagy and Autophagy-Related Proteins in Cancer. Molecular Cancer, 19, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[5] 陈柳, 李敏, 王晓萍, 等. 肝脏细胞自噬在肝纤维化中的作用研究进展[J]. 药学研究, 2020, 39(9): 540-544.
[6] De Duve, C. and Wattiaux, R. (1966) Functions of Lysosomes. Annual Review of Physiology, 28, 435-492. [Google Scholar] [CrossRef] [PubMed]
[7] 杜灿灿, 刘丽姗, 李文静, 等. 自噬调控细胞代谢平衡的研究进展[J]. 中国细胞生物学学报, 2020, 42(11): 2003-2013.
[8] Oku, M. and Sakai, Y. (2018) Three Distinct Types of Microautophagy Based on Membrane Dynamics and Molecular Machineries. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology, 406, e1800008. [Google Scholar] [CrossRef] [PubMed]
[9] Filali, M.Y., Hunter, C., Roccio, F., et al. (2022) The ménage à trois of Autophagy, Lipid Droplets and Liver Disease. Autophagy, 18, 50-72. [Google Scholar] [CrossRef] [PubMed]
[10] Liu, S.Z., Yao, S.J., Yang, H., et al. (2023) Autophagy: Regulator of Cell Death. Cell Death & Disease, 14, Article No. 648. [Google Scholar] [CrossRef] [PubMed]
[11] Camuzard, O., Santucci-Darmanin, S., Carle, G.F., et al. (2020) Autophagy in the Crosstalk between Tumor and Microenvironment. Cancer Letters, 490, 143-153. [Google Scholar] [CrossRef] [PubMed]
[12] Alessandrini, F., Pezzè, L. and Ciribilli, Y. (2017) LAMPs: Shedding Light on Cancer Biology. Seminars in Oncology, 44, 239-253. [Google Scholar] [CrossRef] [PubMed]
[13] Jung, C.H., Jun, C.B., Ro, S.-H., et al. (2009) ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery. Molecular Biology of the Cell, 20, 1992-2003. [Google Scholar] [CrossRef] [PubMed]
[14] Morgan, N.E., Cutrona, M.B. and Simpson, J.C. (2019) Multitasking Rab Proteins in Autophagy and Membrane Trafficking: A Focus on Rab33b. International Journal of Molecular Sciences, 20, Article No. 3916. [Google Scholar] [CrossRef] [PubMed]
[15] Esclatine, A., Chaumorcel, M. and Codogno, P. (2009) Macroautopha-gy Signaling and Regulation. Current Topics in Microbiology and Immunology, 335, 33-70. [Google Scholar] [CrossRef] [PubMed]
[16] Saftig, P., Beertsen, W. and Eskelinen, E. (2008) LAMP-2: A Control Step for Phagosome and Autophagosome Maturation. Autophagy, 4, 510-512. [Google Scholar] [CrossRef] [PubMed]
[17] 陈颖, 傅念, 阳学风, 等. 自噬在肝纤维化中作用的研究进展[J]. 广东医学, 2015(20): 3244-3246.
[18] Omenetti, A., Choi, S., Michelotti, G., et al. (2011) Hedgehog Signaling in the Liver. Journal of Hepatology, 54, 366-373. [Google Scholar] [CrossRef] [PubMed]
[19] Cai, Y.D., Zheng, H.X., Gong, W., et al. (2011) The Role of Hedgehog Signaling Pathway in Liver Regeneration. Hepato-Gastroenterology, 58, 2071-2076.
[20] Chen, M., Liu, J.X., Yang, W.Q., et al. (2017) Lipopolysaccharide Mediates Hepatic Stellate Cell Ac-tivation by Regulating Autophagy and Retinoic Acid Signaling. Autophagy, 13, 1813-1827. [Google Scholar] [CrossRef] [PubMed]
[21] Waltz, P., Carchman, E.H., Young, A.C., et al. (2011) Lip-opolysaccaride Induces Autophagic Signaling in Macrophages via a TLR4, Heme Oxygenase-1 Dependent Pathway. Autophagy, 7, 315-320. [Google Scholar] [CrossRef] [PubMed]
[22] Kang, R., Tang, D., Schapiro, N.E., et al. (2010) The Receptor for Ad-vanced Glycation End Products (RAGE) Sustains Autophagy and Limits Apoptosis, Promoting Pancreatic Tumor Cell Survival. Cell Death and Differentiation, 17, 666-676. [Google Scholar] [CrossRef] [PubMed]
[23] 陈丽娴. COX-2通过PI3K/Akt/mTOR信号通路抑制HSC-T6自噬[D]: [硕士学位论文]. 衡阳: 南华大学, 2022.
[24] Tao, Y., Wang, N.N., Qiu, T.M., et al. (2020) The Role of Au-tophagy and NLRP3 Inflammasome in Liver Fibrosis. BioMed Research International, 2020, Article ID: 7269150. [Google Scholar] [CrossRef] [PubMed]
[25] Mohammed, S., Nicklas, E.H., Thadathil, N., et al. (2021) Role of Necroptosis in Chronic Hepatic Inflammation and Fibrosis in a Mouse Model of Increased Oxidative Stress. Free Radi-cal Biology & Medicine, 164, 315-328. [Google Scholar] [CrossRef] [PubMed]
[26] Parola, M. and Pinzani, M. (2019) Liver Fibrosis: Path-ophysiology, Pathogenetic Targets and Clinical Issues. Molecular Aspects of Medicine, 65, 37-55. [Google Scholar] [CrossRef] [PubMed]
[27] 刘洁. Hif-1靶基因Bnip3在肝星状细胞活化中调控自噬机制的研究[D]: [硕士学位论文]. 武汉: 华中科技大学, 2019.
[28] Das, N., Mandala, A., Naaz, S., et al. (2017) Melato-nin Protects against Lipid-Induced Mitochondrial Dysfunction in Hepatocytes and Inhibits Stellate Cell Activation during Hepatic Fibrosis in Mice. Journal of Pineal Research, 62, e12404. [Google Scholar] [CrossRef] [PubMed]
[29] Choi, S.S., Sicklick, J.K., Ma, Q., et al. (2006) Sustained Activation of Rac1 in Hepatic Stellate Cells Promotes Liver Injury and Fibrosis in Mice. Hepatology (Baltimore, Md.), 44, 1267-1277. [Google Scholar] [CrossRef] [PubMed]
[30] Nazim, U.M. and Park, S.-Y. (2015) Genistein Enhances TRAIL-Induced Cancer Cell Death via Inactivation of Autophagic Flux. Oncology Reports, 34, 2692-2698. [Google Scholar] [CrossRef] [PubMed]
[31] Chung, K.W., Kim, K.M., Choi, Y.J., et al. (2017) The Critical Role Played by Endotoxin-Induced Liver Autophagy in the Maintenance of Lipid Metabolism during Sepsis. Autophagy, 13, 1113-1129. [Google Scholar] [CrossRef] [PubMed]
[32] Lodder, J., Denaës, T., Chobert, M.-N., et al. (2015) Mac-rophage Autophagy Protects against Liver Fibrosis in Mice. Autophagy, 11, 1280-1292. [Google Scholar] [CrossRef] [PubMed]
[33] Zhu, J., Wu, J., Frizell, E., et al. (1999) Rapamycin Inhibits Hepatic Stellate Cell Proliferation in Vitro and Limits Fibrogenesis in an in Vivo Model of Liver Fibrosis. Gastroenterol-ogy, 117, 1198-1204. [Google Scholar] [CrossRef
[34] 李媛, 郑亚东, 龙富立, 等. 白花香莲解毒颗粒调控AMPK/mTOR通路抑制肝星状细胞自噬和活化的作用机制研究[J]. 中药材, 2023(2): 469-473.
[35] 唐菀, 赵楠, 张晓珣, 等. 青蒿琥酯通过PI3K/Akt/mTOR信号通路改善DDC诱导的胆汁淤积性肝纤维化[J]. 陆军军医大学学报, 2023, 45(10): 1001-1009.
[36] 黄秀昆, 孙雪梅, 韦秀桂, 等. 老鼠簕生物碱A对肝纤维化大鼠PI3K/Akt/mTOR/p70S6K信号通路的影响[J]. 中草药, 2019, 50(2): 457-461.
[37] Gong, P.F. and Cederbaum, A.I. (2006) Transcription Factor Nrf2 Protects HepG2 Cells against CYP2E1 plus Arachidonic Acid-Dependent Toxicity. The Journal of Biological Chemistry, 281, 14573-14579. [Google Scholar] [CrossRef
[38] Komatsu, M., Kurokawa, H., Waguri, S., et al. (2010) The Selective Autophagy Substrate p62 Activates the Stress Responsive Transcription Factor Nrf2 through Inactivation of Keap1. Na-ture Cell Biology, 12, 213-223. [Google Scholar] [CrossRef] [PubMed]
[39] 宋鹏书, 潘火珍, 廖明. Taurine、EGCG和genistein联合对体外活化肝星状细胞自噬的影响[J]. 中国病理生理杂志, 2018, 34(10): 1895-1899.
[40] 王莹, 徐渴阳, 包剑锋. 细胞自噬对氧化应激通路的调节及其对肝纤维化的影响[J]. 中国卫生检验杂志, 2020, 30(14): 1716-1718.
[41] 刘曼. Nrf2-Keap1-ARE信号通路在自噬调控酒精诱导肝星状细胞增殖活化中的作用及相关机制研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2014.
[42] 弋国红. 刍议张仲景对阴阳理论的应用[J]. 中国中医基础医学杂志, 2018, 24(6): 719-720+736.
[43] 李建省, 司富春. 肿瘤细胞凋亡的中医阴阳理论阐释[J]. 辽宁中医杂志, 2010, 37(6): 1034-1035.
[44] 许文婷, 杨佩颖, 贾英杰, 等. 从中医角度论细胞自噬[J]. 四川中医, 2015, 33(5): 34-35.
[45] 辛鑫, 胡义扬. 中医对肝纤维化的认识[J]. 肝博士, 2022(2): 32.
[46] 徐列明, 刘平, 沈锡中, 等. 肝纤维化中西医结合诊疗指南(2019年版) [J]. 中国中西医结合杂志, 2019, 39(11): 1286-1295.
[47] 黄瑶瑶, 孙建光. 基于细胞自噬机制应用中医药治疗肝纤维化研究进展[J]. 山西中医, 2022, 38(8): 62-64.
[48] 徐渴阳, 苏晓倩, 包剑锋. 扶正化瘀胶囊对气虚血瘀型肝纤维化模型大鼠细胞自噬基因LC3II和p62的干预作用[J]. 浙江中西医结合杂志, 2019, 29(4): 281-284+351.
[49] 赵志敏, 刘成海. 扶正化瘀方抗肝纤维化的主要作用机制与效应物质[J]. 上海医药, 2016, 37(13): 13-16.
[50] 牛媛媛, 汪龙德, 毛兰芳, 胥文娟, 张萍, 符博雅. 基于网络药理学探讨化瘀软肝胶囊对肝纤维化大鼠的肝脏保护作用[J]. 中成药, 2023, 45(9): 3104-3109.
[51] 孟萍, 南月敏, 赵素贤. 益气活血方对肝纤维化大鼠肝细胞凋亡的影响[J]. 河北中医药学报, 2020, 35(6): 1-5.
[52] 孔德松, 张自力, 张峰, 等. 姜黄素通过影响自噬调控肝细胞上皮间质转化及肝纤维化进程的作用与机制研究[J]. 中国药理学通报, 2019, 35(10): 1388-1393.